Development and preliminary validation of a PICC-related venous thrombosis risk prediction model for cancer patients: A systematic review and meta-analysis predominantly based on Chinese populations
Asia-Pacific Journal of Oncology Nursing · 2026-12 · 13 · 100839
DOI: 10.1016/j.apjon.2025.100839 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Asia-Pacific Journal of Oncology Nursing, 2026-12. Verfasst von Jiwen Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nursing, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and P…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Chinese Academy of Medical Sciences & Peking Union Medical College, Chinese Academy of Medical Sciences Initiative for Innovative Medicine.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
To identify key risk factors for peripherally inserted central catheter -related deep venous thrombosis (PICC-RVT) in patients with cancer through a systematic review and meta-analysis, develop risk prediction model and validate its performance.
Methods
A systematic literature search was performed in Pubmed, EMBASE, Web of Science (core collection), Scopus, CINAHL and Ovid databases from the time of their inception to June 2025. Study quality was assessed using the Newcastle-Ottawa Scale (NOS) checklist. Meta-analysis was performed using RevMan 5.4 statistical software to identify independent risk factors for PICC-RVT in adult patients with cancer, then the effect of each independent risk factor was determined using β - formation conversion for developing the risk predictive model. Finally, we collected the clinical datal of 338 adult patients with cancer who underwent PICC catheterization from June 2024 to May 2025 to evaluate the predictive performance of the risk predictive model by drawing the receiver of curve (ROC).
Results
A total of 32 cohort studies involving 28,813 individuals (28 from China, 2 from UK, 1 each from US and Canada) were included. Twenty-one independent risk factors were identified through meta-analysis. The risk prediction model was developed using β - coefficient transformation: pooled odds ratios (ORs) from meta-analysis were converted to β coefficients through natural logarithmic transformation (β = ln[OR]), then each β - coefficient was multiplied by 10 and rounded to one decimal place to create a point-based scoring system. The total risk score was calculated by summing individual factor scores. Preliminary external validation was conducted in 338 patients with cancer (15 thrombosis events, 4.4% incidence) from a single Chinese center, yielding an area under curve (AUC) of 0.792 (95% [confidence interval (CI)] 0.653-0.931). The model showed acceptable calibration (Hosmer-Lemeshow P = 0.082) but validation was underpowered (15 events vs. recommended 100+ events for precise performance estimation).
Conclusions
This study developed a PICC-RVT risk prediction model based primarily on Chinese patients with cancer. The model demonstrated moderate discrimination in preliminary single-center validation, but requires multi-center validation with adequate event numbers before clinical implementation. The model provides a framework for PICC-RVT risk stratification in Chinese and similar healthcare settings.
Systematic review registration
PROSPERO (CRD420250651190).
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nursing, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Hepatobiliary Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Thoracic Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
- Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Förderung
- Chinese Academy of Medical Sciences & Peking Union Medical College
- Chinese Academy of Medical Sciences Initiative for Innovative Medicine
Zitieren
APA
Zhang, J., Li, C., Zhang, H., Wu, W., Sun, X., & Zhang, W. (2026). Development and preliminary validation of a PICC-related venous thrombosis risk prediction model for cancer patients: A systematic review and meta-analysis predominantly based on Chinese populations. Asia-Pacific Journal of Oncology Nursing, 13, 100839. https://doi.org/10.1016/j.apjon.2025.100839
Vancouver
Zhang J, Li C, Zhang H, Wu W, Sun X, Zhang W. Development and preliminary validation of a PICC-related venous thrombosis risk prediction model for cancer patients: A systematic review and meta-analysis predominantly based on Chinese populations. Asia-Pacific Journal of Oncology Nursing. 2026;13:100839. doi:10.1016/j.apjon.2025.100839
BibTeX
@article{Zhang2026,
author = {Zhang, Jiwen and Li, Caiyun and Zhang, Huijuan and Wu, Wenbo and Sun, Xiaoshuang and Zhang, Wei},
title = {Development and preliminary validation of a PICC-related venous thrombosis risk prediction model for cancer patients: A systematic review and meta-analysis predominantly based on Chinese populations},
journal = {Asia-Pacific Journal of Oncology Nursing},
year = {2026},
volume = {13},
pages = {100839},
doi = {10.1016/j.apjon.2025.100839}
}
EUVIMED